Back
Generation Bio Vs. Lexicon Pharmaceuticals Industry Stock Comparison
Sell
24
GBIO
Generation Bio
Last Price:
$0.62
Seasonality Move:
10.01%
Sell
26
LXRX
Lexicon Pharmaceuticals
Last Price:
$0.73
Seasonality Move:
-7.2%
Sell
24
Generation Bio (GBIO)
is a Sell
Is Generation Bio a Buy, Sell or Hold?
-
The current Generation Bio [GBIO] share price is $0.66. The Score for GBIO is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
GBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Lexicon Pharmaceuticals (LXRX)
is a Sell
Is Lexicon Pharmaceuticals a Buy, Sell or Hold?
-
The current Lexicon Pharmaceuticals [LXRX] share price is $0.74. The Score for LXRX is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
LXRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBIO Stock Price Chart
What is Generation Bio's stock price today?
-
The Generation Bio share price today is $0.66Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GBIO is experiencing selling pressure, which indicates risk of future bearish movement.
LXRX Stock Price Chart
What is Lexicon Pharmaceuticals's stock price today?
-
The Lexicon Pharmaceuticals share price today is $0.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LXRX is experiencing slight selling pressure.
GBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 31.63 | Sell |
Chaikin Money Flow: | -331226 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 46.44 | Sell |
Chaikin Money Flow: | -2814887 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.68 | Sell |
20-day SMA: | 0.78 | Sell |
50-day SMA: | 0.97 | Sell |
200-day SMA: | 2.19 | Sell |
8-day EMA: | 0.69 | Sell |
20-day EMA: | 0.77 | Sell |
50-day EMA: | 1.02 | Sell |
200-day EMA: | 1.92 | Sell |
LXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.74 | Buy |
20-day SMA: | 0.79 | Sell |
50-day SMA: | 0.78 | Sell |
200-day SMA: | 1.44 | Sell |
8-day EMA: | 0.75 | Sell |
20-day EMA: | 0.77 | Sell |
50-day EMA: | 0.84 | Sell |
200-day EMA: | 1.3 | Sell |
Generation Bio Earnings Growth & GBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.10 per share.
Lexicon Pharmaceuticals Earnings Growth & LXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.06 per share.
Generation Bio Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lexicon Pharmaceuticals Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |